Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect

Sorafenib resistance is a major challenge in the therapy for advanced hepatocellular carcinoma (HCC). However, the underlying molecular mechanisms of HCC resistance to sorafenib remain unclear. Activator of thyroid and retinoid receptor (ACTR, also known as SRC‐3), overexpressed in HCC patients, pla...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Sci
Main Authors: Ma, Luyuan, Liu, Wenpeng, Xu, An, Ji, Quanbo, Ma, Yongfu, Tai, Yanhong, Wang, Yadong, Shen, Chuan, Liu, Ying, Wang, Tao, Han, Juqiang, Zhao, Caiyan
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7293092/
https://ncbi.nlm.nih.gov/pubmed/32279388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14412
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker